Reuters Health

• Trump Administration Says California Can't Require Insurers to Cover Abortion The Trump administration said on Friday that California cannot require health insurers to cover abortions and threatened to cut some federal healthcare funds unless it pulls that requirement.
  Reuters Health Information, January 24, 2020
• Bayer Faces Fourth U.S. Roundup Cancer Trial in Monsanto's Hometown Bayer AG is set to face a fourth U.S. jury trial over allegations that its Roundup weed killer causes cancer, with four cancer patients in the hometown of its agricultural subsidiary Monsanto scheduled to begin making their case on Friday.
  Reuters Health Information, January 24, 2020
• JAK Inhibitors Tied to Increased Risk of Herpes Zoster in IBD, Other Immune-Mediated Diseases Patients with inflammatory bowel disease (IBD) or other immune-mediated conditions may be at increased risk of herpes zoster infection if treated with Janus kinase (JAK) inhibitors, a systematic review and meta-analysis suggests.
  Reuters Health Information, January 24, 2020
• High Rates of Chronic Pain, PTSD in Firearm-Injury Survivors Firearm-injury survivors have a much higher burden of chronic pain and post-traumatic stress disorder (PTSD) and worse mental and physical quality of life than car-crash survivors with similar injuries, new findings show.
  Reuters Health Information, January 24, 2020
• Microbiome-Targeted Diet May Improve Symptoms in IBD Patients A diet targeting the microbiome of patients with inflammatory bowel disease (IBD) can improve gut health and reduce symptoms, results of a small study suggest.
  Reuters Health Information, January 24, 2020
• Cannabinoids Do Not Reduce Cancer-Related Pain, Has No Clear Effect on Sleep Problems Cannabinoids do not reduce cancer-related pain, and their effects on sleep problems in patients with chronic pain are unclear, according to a pair of new studies.
  Reuters Health Information, January 24, 2020
• Clinical Markers of Vitiligo Tied to Disease Progression The presence of at least one established clinical marker of vitiligo is associated with disease progression at follow-up, researchers from China report.
  Reuters Health Information, January 24, 2020
• Dasatinib Beats Imatinib in Childhood Leukemia The second-generation Abl-tyrosine kinase inhibitor dasatinib is more effective in children with Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) than the first-generation inhibitor imatinib mesylate, according to new research.
  Reuters Health Information, January 24, 2020
• Epizyme Prices Rare Tissue Cancer Treatment at $15,500 a Month Epizyme Inc on Thursday priced its treatment for an ultra rare, slow growing type of cancer that affects soft tissue at $15,500 per month after getting an approval from the U.S. Food and Drug Administration.
  Reuters Health Information, January 24, 2020
• Roche's Tecentriq Fails Trial in Form of Urothelial Cancer Roche's immunotherapy Tecentriq failed a late-stage clinical trial in a form of urothelial cancer, the Swiss drugmaker said on Friday.
  Reuters Health Information, January 24, 2020
• Athletics-'They're Fast, But Are They Fair?' Amateur Runners Face Nike Dilemma British amateur runner and triathlete Holly Grundon was delighted to smash a long-held personal speed target - to finish a half marathon in less than 1 hour and 30 minutes.
  Reuters Health Information, January 24, 2020
• Athletics Body to Tighten Rules After Nike's Vaporfly Helps Records Tumble-Sources Athletics' ruling body will tighten regulations governing shoe technology, two sources familiar with the matter said, after Nike's popular Vaporfly brand helped re-write running records and sparked debate about whether it was "technological doping."
  Reuters Health Information, January 24, 2020
• China Building 1,000-Bed Hospital Over the Weekend to Treat Coronavirus The Chinese city of Wuhan is rapidly building a new 1,000-bed hospital to treat victims of a new coronavirus, mobilizing machinery to get it ready by early next week, state media said.
  Reuters Health Information, January 24, 2020
• J&J CEO to Testify at Trial for First Time on Baby Powder Risks Johnson & Johnson Chief Executive Officer Alex Gorsky was set to be called as a witness on Monday in what would be his first appearance in a jury trial over allegations that the company's Baby Powder causes cancer.
  Reuters Health Information, January 27, 2020
• GI-Bleeding Prophylaxis Benefits Higher-Risk Critically Ill Patients Prophylaxis with proton-pump inhibitors (PPIs) or histamine-2-receptor antagonists (H2RAs) significantly reduces gastrointestinal bleeding in higher-risk critically ill patients, but not in patients at low risk of bleeding, according to a systematic review and network meta-analysis.
  Reuters Health Information, January 23, 2020
• Turkey to Start Screening Passengers on Flights From China -Anadolu
  Reuters Health Information, January 23, 2020
• Work to Start on Three Possible China Virus Vaccines - Epidemic Response Group
  Reuters Health Information, January 23, 2020
• Nasal and Skin Decolonization Safely Replaces Contact Precautions for MRSA-Colonized Patients Nasal and skin decolonization safely and less expensively replaced contact precautions for patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) at one U.S. hospital network, according to a new report.
  Reuters Health Information, January 23, 2020
• Reduced 'Sleep Pressure' Contributes to Insomnia in Autism Disturbances in sleep homeostasis, manifested as reduced pressure to sleep after being awake for a longer period, contribute to insomnia in young children with autism-spectrum disorder (ASD), researchers from Israel report.
  Reuters Health Information, January 23, 2020
• Single PSA Test May Reveal Long-Term Prostate-Cancer Risk Baseline prostate-specific antigen (PSA) levels in midlife are associated with the subsequent risk of clinically significant prostate cancer, according to a secondary analysis of a large clinical trial.
  Reuters Health Information, January 23, 2020